Page last updated: 2024-10-24

cefuroxime and Coagulation Disorders, Blood

cefuroxime has been researched along with Coagulation Disorders, Blood in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van den Berg, SA1
Verwer, PE1
Idema, RN1
Van Guldener, C1

Other Studies

1 other study available for cefuroxime and Coagulation Disorders, Blood

ArticleYear
Transient cefuroxime/metronidazole treatment induced factor V antibodies.
    BMJ case reports, 2014, Aug-19, Volume: 2014

    Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antibodies; Blood Coagulation Disorders; Cefuroxime

2014